Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lp-PRP versus conventional PRP intradiscal injection combined with physiotherapy for lumbar degenerative disc disease
TCTR20260824011Phase 0Not yet recruiting
- Sponsor
- Dr. Kazi Md. Amran Hossain
- Start
- Sep 2026
- Countries
- 1
01
Overview
Phase 0, open-label trial of Leukocyte-Poor Platelet Rich Plasma and platelet-rich plasma in lumbosacral disc disease (2 arms), sponsored by Dr. Kazi Md. Amran Hossain. Primary endpoints: Pain intensity and Pain pressure threshold. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
Leukocyte-Poor Platelet Rich Plasmaplatelet-rich plasma
03
Conditions
lumbosacral disc disease
Beyond the preview
Go deeper on TCTR20260824011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260824011.